UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059628
Receipt number R000068199
Scientific Title Immunological Mechanisms of Chronic Nasopharyngitis and Therapeutic Effects of Epipharyngeal Abrasive Therapy (EAT)
Date of disclosure of the study information 2025/11/04
Last modified on 2025/11/03 21:58:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the Therapeutic Effects of Epipharyngeal Abrasive Therapy (EAT) and Immune Profile Changes in Chronic Nasopharyngitis

Acronym

Chronic Nasopharyngitis and EAT Effects

Scientific Title

Immunological Mechanisms of Chronic Nasopharyngitis and Therapeutic Effects of Epipharyngeal Abrasive Therapy (EAT)

Scientific Title:Acronym

Immune Profiling and EAT Effects in Chronic Nasopharyngitis

Region

Japan


Condition

Condition

Chronic Nasopharyngitis

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To quantitatively evaluate immune profile changes before and after Epipharyngeal Abrasive Therapy (EAT) in patients with chronic nasopharyngitis using flow cytometry of scraped epithelial cells and peripheral blood. The study also aims to identify disease-specific immune characteristics by comparing with healthy controls.

Basic objectives2

Others

Basic objectives -Others

This study aims to quantitatively assess immune profile changes in chronic nasopharyngitis and clarify the immunomodulatory effects of Epipharyngeal Abrasive Therapy (EAT).

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Change in CD4/CD8 ratio in scraped epithelial cells and peripheral blood before and after EAT (evaluated at baseline and 3 months after treatment)

Key secondary outcomes

Change in Th17/Treg ratio (baseline and 3 months)
Transition of subjective symptom scores (VAS) at baseline, 1 month, and 3 months
Change in endoscopic inflammatory findings (baseline and 3 months)
Comparison of immune profiles with healthy controls


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Patients with chronic nasopharyngitis will receive Epipharyngeal Abrasive Therapy (EAT) once a week for 4 weeks. Peripheral blood and epipharyngeal swab samples will be collected before and after the intervention to evaluate changes in immune cell composition.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Participants diagnosed with chronic nasopharyngitis, aged 15 years or older, who consent to EAT and understand the study purpose and provide written informed consent.

Key exclusion criteria

Individuals with severe systemic diseases, those using immunosuppressive agents, pregnant or breastfeeding women, or those deemed inappropriate by the principal investigator.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Manabu
Middle name
Last name Mogitate

Organization

Mogitate Medical Corporation

Division name

Mogitate ENT Clinic

Zip code

2130011

Address

4F-401, Sekiguchi Daiichi Building, 1-2-5 Hisamoto, Takatsu-ku, Kawasaki-shi, Kanagawa, Japan

TEL

0448654187

Email

mogitateentjp@m08.itscom.net


Public contact

Name of contact person

1st name Manabu
Middle name
Last name Mogitate

Organization

Mogitate Medical Corporation

Division name

Mogitate ENT Clinic

Zip code

2130011

Address

4F-401, Sekiguchi Daiichi Building, 1-2-5 Hisamoto, Takatsu-ku, Kawasaki-shi, Kanagawa, Japan

TEL

0448654187

Homepage URL


Email

mogitateentjp@m08.itscom.net


Sponsor or person

Institute

Mogitate Medical Corporation

Institute

Department

Personal name

Manabu Mogitate


Funding Source

Organization

Mogitate Medical Corporation

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Manabu Mogitate


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board: Ota General Hospital Ethics Committee

Address

1-50 Nisshin-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa, Japan

Tel

0442440131

Email

info@ota-g-hospital.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 11 Month 03 Day

Date of IRB


Anticipated trial start date

2025 Year 11 Month 04 Day

Last follow-up date

2026 Year 11 Month 03 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 11 Month 03 Day

Last modified on

2025 Year 11 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068199